Market revenue in 2023 | USD 6,789.9 million |
Market revenue in 2030 | USD 37,241.4 million |
Growth rate | 27.5% (CAGR from 2023 to 2030) |
Largest segment | Wearable devices |
Fastest growing segment | MHealth |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Wireless Sensor Technology, MHealth, Telehealth, Wearable Devices, Remote Patient Monitoring |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, AT&T, Athenahealth, Abbott Laboratories, Koninklijke Philips NV, Hill-Rom, Medtronic PLC, OMRON Corp, Fitbit, Garmin Ltd, ResMed Inc, Siren |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital patient monitoring devices market will help companies and investors design strategic landscapes.
Wearable devices was the largest segment with a revenue share of 31.3% in 2023. Horizon Databook has segmented the Japan digital patient monitoring devices market based on wireless sensor technology, mhealth, telehealth, wearable devices, remote patient monitoring covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is one of the lucrative markets for digital patient monitoring devices in the Asia Pacific region. The factors such as availability of advanced products, growing awareness regarding patient monitoring devices and presence of well-established companies, is expected to boost the market growth.
Cardiovascular diseases are a major cause of mortality and morbidity in Japan. According to the Ministry of Health, Labour, and Welfare of Japan, approximately 162 males per 100,000 population perished from heart diseases in Japan in 2018, an increase from approximately 135 men per 100,000 inhabitants in 2007.
Heart diseases, apart from hypertensive heart diseases, were the second leading cause of death in the country's male population in 2018, after malignant neoplasms. It is therefore expected to have a positive impact on the market. Therefore, the growing burden of such diseases is expected to increase the demand for monitoring systems in the market during the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan digital patient monitoring devices market , including forecasts for subscribers. This country databook contains high-level insights into Japan digital patient monitoring devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account